Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.490185
Title: Development of poly(vinylpyrrolidinone) newtorks for treatment of skin graft contracture
Author: Smith, Louise Elizabeth
Awarding Body: University of Sheffield
Current Institution: University of Sheffield
Date of Award: 2008
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Skin graft contracture is a problem facing many bums patients treated with skin grafts. Currently grafts under suspicion of contraction are treated with pressure garments to prevent contractures progressing. Patients may have to wear these for many months however once contractures have formed surgical intervention is commonly required. The aim of this project was to develop a hydrogel drug delivery system to prevent or reduce skin graft contracture. Two potential anti-contraction agents, identified based on prior work from our laboratory were initially examined for their effectiveness in preventing contracture formation using two 3D models of contraction - collagen I gels and a reconstructed human skin model. 13-aminopropionitrile (13APN), a noncompetitive lysyl oxidase inhibitor significantly reduced contraction in the reconstructed skin model but not the collagen gel model while 4-methyl umbelliferone (4-MU) reduced contraction in both models. For hydrogel drug delivery poly(N-vinylpyrrolidinone) (PNVP) hydrogels were developed with material properties suitable for use as a non-cytotoxic wound dressing. Two crosslinked PNVP's were investigated, one crosslinked with ethylene glycol dimethacrylate (EGDMA) and the other crosslinked with diethyleneglycol bis allylcarbonate (DEGBAC). The different crosslinkers led to hydrogels with different mechanical and slightly different biological properties. Although neither hydrogel proved to be suitable for culturing cells on, indirect contact with both showed them to be biocompatible and in some cases stimulatory to fibroblasts. These hydrogels were evaluated for their uptake and release of 13APN and 4-MU. Hydrogels were then used to deliver 13APN and 4-MU to reduce skin cell contraction in both collagen gels and the reconstructed skin model with some promising preliminary results showing hydrogels releasing 4-MU to reduce contraction in the 3D collagen gel model.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.490185  DOI: Not available
Share: